Short Information | AgeX Therapeutics Inc. (NYSE:AGE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 120,006 |
Total Actual Volume | 2,910,768 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 6,000 |
Average Short Percentage | 1.95% |
Is there a AGE Short Squeeze or Breakout about to happen?
See the AGE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-26-2024 | $12.59 | $11.1 | $12.59 | $11.1 | 3,753 | 1 | 0.03% |
03-25-2024 | $12.528 | $12.6 | $13.37 | $12.1738 | 4,414 | 9 | 0.2% |
03-22-2024 | $13.54 | $13.03 | $13.8996 | $13.03 | 2,982 | 8 | 0.27% |
03-21-2024 | $13 | $13.29 | $14 | $13 | 8,499 | 14 | 0.16% |
03-20-2024 | $15.9 | $13.01 | $15.9 | $12.585 | 21,150 | 721 | 3.41% |
03-18-2024 | $21.99 | $16.9022 | $21.99 | $15.15 | 23,467 | 189 | 0.81% |
03-15-2024 | $15.0001 | $22.32 | $22.32 | $11.5127 | 24,850 | 582 | 2.34% |
03-14-2024 | $0.45 | $0.51 | $0.5999 | $0.430001 | 566,036 | 47,634 | 8.42% |
03-13-2024 | $0.46 | $0.42 | $0.649 | $0.42 | 1,407,941 | 51,079 | 3.63% |
03-12-2024 | $0.34 | $0.4545 | $0.4574 | $0.34 | 362,472 | 10,924 | 3.01% |
03-11-2024 | $0.3581 | $0.348 | $0.3781 | $0.3401 | 102,792 | 3,171 | 3.08% |
03-08-2024 | $0.384899 | $0.38 | $0.39 | $0.3674 | 38,380 | 110 | 0.29% |
03-07-2024 | $0.38 | $0.38 | $0.39 | $0.360001 | 60,604 | 937 | 1.55% |
03-06-2024 | $0.3879 | $0.39 | $0.3902 | $0.37 | 11,161 | 266 | 2.38% |
03-04-2024 | $0.36 | $0.3925 | $0.3975 | $0.355 | 77,251 | 103 | 0.13% |
03-01-2024 | $0.3885 | $0.37 | $0.395 | $0.37 | 20,906 | 201 | 0.96% |
02-29-2024 | $0.3711 | $0.381 | $0.399 | $0.361 | 52,440 | 3,202 | 6.11% |
02-28-2024 | $0.3894 | $0.371 | $0.3895 | $0.36 | 34,836 | 480 | 1.38% |
02-27-2024 | $0.38 | $0.3897 | $0.4171 | $0.379 | 55,441 | 251 | 0.45% |
02-26-2024 | $0.39 | $0.3705 | $0.395 | $0.3705 | 31,393 | 124 | 0.39% |
News, Short Squeeze, Breakout and More Instantly...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...